Literature DB >> 23081796

The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination.

Muhammad N Zahid1, Marine Turek, Fei Xiao, Viet Loan Dao Thi, Maryse Guérin, Isabel Fofana, Philippe Bachellier, John Thompson, Leen Delang, Johan Neyts, Dorothea Bankwitz, Thomas Pietschmann, Marlène Dreux, François-Loïc Cosset, Fritz Grunert, Thomas F Baumert, Mirjam B Zeisel.   

Abstract

UNLABELLED: Scavenger receptor class B type I (SR-BI) is a high-density lipoprotein (HDL) receptor highly expressed in the liver and modulating HDL metabolism. Hepatitis C virus (HCV) is able to directly interact with SR-BI and requires this receptor to efficiently enter into hepatocytes to establish productive infection. A complex interplay between lipoproteins, SR-BI and HCV envelope glycoproteins has been reported to take place during this process. SR-BI has been demonstrated to act during binding and postbinding steps of HCV entry. Although the SR-BI determinants involved in HCV binding have been partially characterized, the postbinding function of SR-BI remains largely unknown. To uncover the mechanistic role of SR-BI in viral initiation and dissemination, we generated a novel class of anti-SR-BI monoclonal antibodies that interfere with postbinding steps during the HCV entry process without interfering with HCV particle binding to the target cell surface. Using the novel class of antibodies and cell lines expressing murine and human SR-BI, we demonstrate that the postbinding function of SR-BI is of key impact for both initiation of HCV infection and viral dissemination. Interestingly, this postbinding function of SR-BI appears to be unrelated to HDL interaction but to be directly linked to its lipid transfer function.
CONCLUSION: Taken together, our results uncover a crucial role of the SR-BI postbinding function for initiation and maintenance of viral HCV infection that does not require receptor-E2/HDL interactions. The dissection of the molecular mechanisms of SR-BI-mediated HCV entry opens a novel perspective for the design of entry inhibitors interfering specifically with the proviral function of SR-BI.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23081796     DOI: 10.1002/hep.26097

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  44 in total

1.  Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.

Authors:  Huahao Fan; Luhua Qiao; Kyung-Don Kang; Junfen Fan; Wensheng Wei; Guangxiang Luo
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.

Authors:  George Koutsoudakis; Alexia Paris de León; Carolina Herrera; Marcus Dorner; Gemma Pérez-Vilaró; Sébastien Lyonnais; Santiago Grijalvo; Ramon Eritja; Andreas Meyerhans; Gilles Mirambeau; Juana Díez
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 3.  Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions.

Authors:  Steven W Johnson; Dorothea K Thompson; Brianne Raccor
Journal:  Curr Infect Dis Rep       Date:  2017-06       Impact factor: 3.725

Review 4.  The ins and outs of hepatitis C virus entry and assembly.

Authors:  Brett D Lindenbach; Charles M Rice
Journal:  Nat Rev Microbiol       Date:  2013-09-10       Impact factor: 60.633

5.  Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.

Authors:  Dorothea Bankwitz; Gabrielle Vieyres; Kathrin Hueging; Julia Bitzegeio; Mandy Doepke; Patrick Chhatwal; Sibylle Haid; Maria Teresa Catanese; Mirjam B Zeisel; Alfredo Nicosia; Thomas F Baumert; Lars Kaderali; Thomas Pietschmann
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

6.  Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.

Authors:  Yoshimi Shimizu; Yoshitaka Shirasago; Masuo Kondoh; Tetsuro Suzuki; Takaji Wakita; Kentaro Hanada; Kiyohito Yagi; Masayoshi Fukasawa
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 7.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

Review 8.  Hepatitis C virus relies on lipoproteins for its life cycle.

Authors:  Germana Grassi; Giorgia Di Caprio; Gian Maria Fimia; Giuseppe Ippolito; Marco Tripodi; Tonino Alonzi
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

9.  Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model.

Authors:  Sara Calattini; Floriane Fusil; Jimmy Mancip; Viet Loan Dao Thi; Christelle Granier; Nicolas Gadot; Jean-Yves Scoazec; Mirjam B Zeisel; Thomas F Baumert; Dimitri Lavillette; Marlène Dreux; François-Loïc Cosset
Journal:  J Biol Chem       Date:  2015-07-29       Impact factor: 5.157

10.  Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies.

Authors:  Isabel Fofana; Laetitia Zona; Christine Thumann; Laura Heydmann; Sarah C Durand; Joachim Lupberger; Hubert E Blum; Patrick Pessaux; Claire Gondeau; Gary M Reynolds; Jane A McKeating; Fritz Grunert; John Thompson; Mirjam B Zeisel; Thomas F Baumert
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.